<DOC>
	<DOCNO>NCT00303407</DOCNO>
	<brief_summary>To determine efficacy measure complication prophylactic anticoagulation use low-molecular weight heparin adult cancer patient palliative care</brief_summary>
	<brief_title>Prophylaxis Venous Thrombo-Embolism Cancer Patients Under Palliative Care</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Nadroparin</mesh_term>
	<criteria>Cancer patient palliative care Patients fully informed condition Signed informed consent No exclusion criterion Absence advance cancer Cancer previously cure Venous thromboembolism diagnose within 6 month prior inclusion Absence discerning capacity Active antithrombotic treatment heparin coumarines Thrombocytopenia &lt; 50G/l PTT &gt; 45sec TP &lt; 35 % Active bleeding Renal failure &lt; 20ml/min Past history heparininduced thrombocytopenia</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2005</verification_date>
</DOC>